Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)
Status:
Suspended
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purposes of the study is to determine the safety and efficacy of human umbilical cord
mesenchymal stem cells (hUC-MSC) in treating Myelodysplastic Syndrome patients.